Expansion of diagnostic activities: SCHOTT signs an agreement to acquire Applied Microarrays Inc.

PHOENIX & MELBOURNE, Australia – (COMMERCIAL THREAD) – SCHOTT MINIFAB, a subsidiary of SCHOTT that develops and manufactures microfluidic devices for point-of-service and life science consumables, has a long-standing close customer relationship with Applied Microarrays Inc. (AMI). Together, they develop biotechnological substrates for diagnostic applications. AMI’s expertise will further strengthen SCHOTT’s ability to deliver a single source contract manufacturing solution. The deal is expected to be finalized in early October.

With this acquisition, SCHOTT MINIFAB considerably expands its biosensor printing capabilities. This is particularly important as demand increases for the manufacture of point-of-care DNA microarray consumables, particularly in applications such as infectious disease detection.

“We are proud to be an end-to-end partner for the global diagnostics industry. Our extensive offering enables us to provide an integrated, single-source collection of high value-added services and products. With the additional bioscience knowledge from AMI, we become an even stronger partner, improving our surface modification, functionalization and deposition capability for glass and polymer products, ”said Greg Wolters, Director of SCHOTT MINIFAB .

“We are joining SCHOTT at a time when the market continues to shift towards point-of-care diagnostics,” adds Alastair Malcolm, CEO of AMI. “Our common knowledge and technical capabilities allow us to offer a more holistic approach while shortening the time to market for customers. ”

AMI will soon be relocating to larger facilities in the Phoenix, Arizona area. Its new location will significantly increase SCHOTT’s manufacturing footprint in the United States to serve its global customer base.

Pioneer – responsible – together

These attributes characterize SCHOTT as a manufacturer of high-tech materials based on special glass. Founder Otto Schott is considered its inventor and has become the pioneer of an entire industry. Always opening up new markets and applications with pioneering spirit and passion – this has been the driving force behind #glasslovers at SCHOTT for over 130 years. Represented in 34 countries, the company is a highly qualified partner for high-tech industries: Healthcare, Home Appliances & Home, Consumer Electronics, Semiconductors & Datacom, Optics, Industry & Energy, Automotive, Astronomy & Aerospace. In fiscal year 2020, its 16,500 employees generated sales of 2.24 billion euros. With the best teams, supported by the best digital tools, the group intends to continue to develop. SCHOTT AG is owned by the Carl Zeiss Foundation, one of the oldest foundations in Germany. It uses the Group’s dividends to promote science. As a founding company, SCHOTT has deeply rooted responsibility towards employees, society and the environment in its DNA. The goal is to become a climate neutral company by 2030.

About Applied DNA Arrays (AMIs)

AMI is a Tempe, Arizona-based company that designs, optimizes, and manufactures DNA and protein biosensors, as well as other DNA chips on glass, plastic, and semiconductors. AMI operates under ISO 9001 and ISO 13485 certification. Since acquiring the microarrays business from GE Healthcare in 2007, AMI has evolved into a full service provider for RUO and Dx devices.

Leave a Reply

Your email address will not be published.